Love staying up to date? Forward this to a friend to subscribe!

This report is brought to you in partnership with Sustainment, a market network dedicated to the success of American Manufacturing. Learn More →

💴 This Week in Manufacturing

Most of the Trump administration’s rapid-fire tariffs may be on pause, but a summarizing statement from the White House this morning highlighting total impact as high as 245% is spurring another wave of conversation. Needless to say, these new tariffs have already had massive impact on US manufacturing. This month’s industry report is a clear sign of brakes amid previous growth, but optimistic corporate investments point toward this as a temporary setback. Let’s dive in!

The March monthly industry review and report highlight a sector grappling with strong uncertainty. The PMI slipped down to 50.2 from 52.7 in February–only a minor decline. However, on a strongly positive note, major companies such as Johnson & Johnson and TSMC have made historic investments to buoy manufacturing production and hiring alike. There’s light at the end of this tunnel.

This week’s headlines carry more positive pharmaceutical news along with 3D printing innovation, supercomputer growth, and more!

Next, this week’s podcasts cover the manufacturing promise of April beyond spring (The Manufacturing Report) and the state of AI in manufacturing (Augmented Ops).

Finally, our Social Video and Fun Fact each explore different innovations for the future of healthcare in the US.

Thanks for joining us!

P.S. Do you have a story to share about innovation at your company? We'd love to profile you! Click here (it’s free)

⚙ Manufacturing Headlines

• Continuum Powders Turns Siemens Scrap Into High-Value 3D Printing Material [3DPrint.com]

• Pharma’s US manufacturing moment [Pharma Voice]

• March manufacturing industry data review [CompanyWeek]

• Wisconsin's Foxconn plant and the future of U.S. manufacturing [NPR]

• Nvidia building AI supercomputers in US for the first time [Quartz]

• Novartis invests $23bn in US manufacturing amid tariff fears [World Pharmaceutical Frontiers]

MONTHLY REVIEW

♨️ US Manufacturing Insights - March

U.S. manufacturing’s early-year momentum faltered in March 2025, as key indicators pointed to a near stall in factory growth amid rising headwinds.

Both major purchasing manager indices reflected a slowdown in March. The S&P Global US Manufacturing PMI fell to 50.2 (seasonally adjusted) from 52.7 in February, indicating only a marginal improvement in operating conditions. March marked the PMI’s third consecutive month above the neutral 50 threshold, but the sharp drop from February’s robust expansion suggests growth essentially stalled.

On the optimistic side, domestic and foreign investments across multiple growing industries such as semiconductors and healthcare show continued faith in the American economy.

Upshot: If the economy navigates the current headwinds without a major downturn, these new investments and a resolution of tariff uncertainties could set the stage for a manufacturing rebound later in the year.

FROM THE FEED

📱The Future of Healthcare & Manufacturing

🤨Did You Know?

The United States is the top producer in the medical device industry with its contribution of

more than 40%

to global revenues.

^{Source: Arterex Medical}

🎧 Podcasts Worth A Listen

CompanyWeek is the voice of the modern manufacturing economy, telling stories of U.S. Manufacturers to showcase workers, innovation, technology, and progress.